Patents by Inventor Katsuhiro Uzawa

Katsuhiro Uzawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170349879
    Abstract: The present invention provides a method for culturing odontoma cells or normal cells, wherein these cells are cultured in the presence of a Rho kinase inhibitor.
    Type: Application
    Filed: July 22, 2015
    Publication date: December 7, 2017
    Inventors: Hideki TANZAWA, Katsuhiro UZAWA, Atsushi KASAMATSU
  • Patent number: 9494594
    Abstract: Provided is a method of determining a therapeutic effect of cancer chemotherapy with an anticancer drug obtained by blending three ingredients, i.e., tegafur, gimeracil, and oteracil potassium as active ingredients (hereinafter abbreviated as S-1) quickly, simply, and accurately before carrying out the cancer chemotherapy. Specifically, provided is a method of determining an administration effect in chemotherapy with S-1, the method comprising: a step (a) of measuring expression level of a decorin gene in a biological sample collected from a subject to be diagnosed; and a step (b) of determining an administration effect of S-1 based on the expression level of the gene obtained from the measurement.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: November 15, 2016
    Assignee: National University Corporation Chiba University
    Inventors: Hideki Tanzawa, Atsushi Kasamatsu, Katsuhiro Uzawa